Restat, the 6^th largest Pharmacy Benefit Manager (PBM) according to Business Insurance, announced today that it will present a poster during the Academy of Managed Care Pharmacy (AMCP) 22^nd Annual Meeting & Showcase, held April 7-10 in San Diego, California. Scott Draeger, Restat’s Pharm D Director of Clinical Services and Jill Harding, Restat’s Clinical Pharmacist, will present the professional abstract entitled, "Prevalence of Diabetes and Lipid-Lowering Medications by Antipsychotic Drug in a Commercial Population."

The team performed a retrospective analysis of commercial pharmacy claims on antipsychotic claims submitted between August 2008 and August 2009. Draeger said the data was then analyzed to identify those antipsychotic claims with concomitant claims for diabetes and lipid-lowering medications. “We concluded that consistent monitoring of metabolic parameters in patients receiving antipsychotic medication is an important step in controlling cardiovascular risk,” said Draeger. “Implementing a more coordinated approach to patient care may help improve the health of this population.”

The information provided will populate the onsite final program as well as other AMCP publications, including the Journal of Managed Care Pharmacy (JMCP). This study was conducted in conjunction with Pfizer.

Dr. Draeger received his PharmD from the University of Wisconsin, Madison. As Director of Clinical Services at Restat, Draeger leads the pharmacy and therapeutics committee, oversees pharmacoeconomic modeling for contracting, prior authorization guideline development, and employer pharmacy claims analysis. He is also serves as an adjunct clinical instructor at the University of Wisconsin, School of Pharmacy. Draeger is a member of the Academy of Managed Care Pharmacy, Pharmacy Society of Wisconsin, American Pain Society, and the College of Psychiatric and Neurologic Pharmacy.

Dr. Harding received her PharmD from the University of Wisconsin and is licensed in the state of Wisconsin. As a Clinical Pharmacist at Restat, Harding is a member of the pharmacy and therapeutics committee, develops prior authorization policies, and works internally as a resource to help educate client groups and service client needs. She also serves as an adjunct clinical instructor at the University of Wisconsin, School of Pharmacy. Harding is also a member of the Academy of Managed Care Pharmacy (AMCP) who actively attends conferences within the organization.

Source: Business Wire